These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26130381)

  • 21. [Role of topical calcineurin inhibitors in dermatology].
    Alomar A
    Actas Dermosifiliogr; 2008 Feb; 99 Suppl 2():1. PubMed ID: 18346422
    [No Abstract]   [Full Text] [Related]  

  • 22. Systemic therapies for severe atopic dermatitis in children and adults.
    Flohr C; Irvine AD
    J Allergy Clin Immunol; 2013 Sep; 132(3):774-774.e6. PubMed ID: 23993356
    [No Abstract]   [Full Text] [Related]  

  • 23. Methotrexate in the Treatment of Moderate to Severe Atopic Dermatitis: A Retrospective Study.
    Shah N; Alhusayen R; Walsh S; Shear NH
    J Cutan Med Surg; 2018; 22(5):484-487. PubMed ID: 29855201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Managing a common disorder in children: Atopic dermatitis.
    Cheigh NH
    J Pediatr Health Care; 2003; 17(2):84-8; quiz 89-90. PubMed ID: 12665731
    [No Abstract]   [Full Text] [Related]  

  • 25. Methotrexate does not impede the development of contact allergy.
    Yfanti I; Nosbaum A; Berard F; Nicolas JF
    Contact Dermatitis; 2018 Mar; 78(3):223-224. PubMed ID: 29430711
    [No Abstract]   [Full Text] [Related]  

  • 26. Methotrexate vs. ciclosporin in the treatment of severe atopic dermatitis in children: a critical appraisal.
    Tsakok T; Flohr C
    Br J Dermatol; 2014 Mar; 170(3):496-8; discussion 498-9. PubMed ID: 24617431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful long-term treatment of severe atopic dermatitis with mycophenolate mofetil.
    Benez A; Fierlbeck G
    Br J Dermatol; 2001 Mar; 144(3):638-9. PubMed ID: 11260038
    [No Abstract]   [Full Text] [Related]  

  • 28. Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults.
    Lyakhovitsky A; Barzilai A; Heyman R; Baum S; Amichai B; Solomon M; Shpiro D; Trau H
    J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):43-9. PubMed ID: 19552716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    van der Laan JR
    Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1816; author reply 1817. PubMed ID: 16121669
    [No Abstract]   [Full Text] [Related]  

  • 30. Two Cancer Patients Receiving Dupilumab for Treatment of Atopic Dermatitis.
    Fowler E; Rosen J; Lev-Tov H; Yosipovitch G
    Acta Derm Venereol; 2019 Sep; 99(10):899-900. PubMed ID: 31037315
    [No Abstract]   [Full Text] [Related]  

  • 31. New and emerging therapies for paediatric atopic dermatitis.
    Vakharia PP; Silverberg JI
    Lancet Child Adolesc Health; 2019 May; 3(5):343-353. PubMed ID: 30904349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted Treatment of Atopic Dermatitis.
    Metin SA; Wallace M
    Skinmed; 2017; 15(2):137-138. PubMed ID: 28528610
    [No Abstract]   [Full Text] [Related]  

  • 33. [Dermatologic treatment. The Danish Society of Dermatology].
    Olesen AK; Jemec GB
    Ugeskr Laeger; 2003 Mar; 165(12):1228. PubMed ID: 12701278
    [No Abstract]   [Full Text] [Related]  

  • 34. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    de Bruin-Weller MS; Bruijnzeel-Koomen CA
    Ned Tijdschr Geneeskd; 2005 May; 149(20):1096-100. PubMed ID: 15932135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methotrexate for Severe Childhood Atopic Dermatitis: Clinical Experience in a Tertiary Center.
    Dvorakova V; O'Regan GM; Irvine AD
    Pediatr Dermatol; 2017 Sep; 34(5):528-534. PubMed ID: 28730617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II.
    Wollenberg A; Barbarot S; Bieber T; Christen-Zaech S; Deleuran M; Fink-Wagner A; Gieler U; Girolomoni G; Lau S; Muraro A; Czarnecka-Operacz M; Schäfer T; Schmid-Grendelmeier P; Simon D; Szalai Z; Szepietowski JC; Taïeb A; Torrelo A; Werfel T; Ring J;
    J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):850-878. PubMed ID: 29878606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atopic and non-atopic eczema.
    Brown S; Reynolds NJ
    BMJ; 2006 Mar; 332(7541):584-8. PubMed ID: 16528081
    [No Abstract]   [Full Text] [Related]  

  • 38. Non-topical management of recalcitrant paediatric atopic dermatitis.
    Chong JH; Koh MJA
    Arch Dis Child; 2017 Jul; 102(7):681-686. PubMed ID: 28209661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-related reduction in allergen-specific T cells associates with clinical response of atopic dermatitis to methotrexate.
    Bateman EA; Ardern-Jones M; Ogg GS
    Br J Dermatol; 2007 Jun; 156(6):1376-7. PubMed ID: 17535236
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug survival and postdrug survival of first-line immunosuppressive treatments for atopic dermatitis: comparison between methotrexate and cyclosporine.
    Law Ping Man S; Bouzillé G; Beneton N; Safa G; Dupuy A; Droitcourt C
    J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):1327-1335. PubMed ID: 29444359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.